Im Cannabis Corp (IMCC) - Net Assets
Based on the latest financial reports, Im Cannabis Corp (IMCC) has net assets worth $-3.62 Million USD as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($31.74 Million) and total liabilities ($35.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Im Cannabis Corp (IMCC) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-3.62 Million |
| % of Total Assets | -11.39% |
| Annual Growth Rate | N/A |
| 5-Year Change | -101.76% |
| 10-Year Change | N/A |
| Growth Volatility | 393.84 |
Im Cannabis Corp - Net Assets Trend (2003–2025)
This chart illustrates how Im Cannabis Corp's net assets have evolved over time, based on quarterly financial data. Also explore how large is Im Cannabis Corp's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Im Cannabis Corp (2003–2025)
The table below shows the annual net assets of Im Cannabis Corp from 2003 to 2025. For live valuation and market cap data, see Im Cannabis Corp market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $-3.62 Million | -214.91% |
| 2024-12-31 | $3.15 Million | -77.04% |
| 2023-12-31 | $13.70 Million | -42.43% |
| 2022-12-31 | $23.80 Million | -88.39% |
| 2021-12-31 | $204.94 Million | +1525.26% |
| 2020-12-31 | $12.61 Million | -51.70% |
| 2019-12-31 | $26.11 Million | +12263.69% |
| 2018-12-31 | $-214.65K | +53.02% |
| 2017-12-31 | $-456.84K | -5.78% |
| 2016-12-31 | $-431.87K | -3.78% |
| 2015-12-31 | $-416.12K | -12.31% |
| 2014-12-31 | $-370.51K | -26.45% |
| 2013-12-31 | $-293.01K | -85.05% |
| 2012-12-31 | $-158.34K | -101.68% |
| 2011-12-31 | $9.44 Million | +0.71% |
| 2010-12-31 | $9.37 Million | +3.93% |
| 2009-12-31 | $9.02 Million | +41.87% |
| 2008-12-31 | $6.36 Million | +166.07% |
| 2007-12-31 | $2.39 Million | +65.16% |
| 2006-12-31 | $1.45 Million | +76.56% |
| 2005-12-31 | $819.27K | -19.49% |
| 2004-12-31 | $1.02 Million | +31.65% |
| 2003-12-31 | $772.97K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Im Cannabis Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 25734483300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $270.52 Million | % |
| Other Comprehensive Income | $-3.81 Million | % |
| Other Components | $2.64 Million | % |
| Total Equity | $-858.00K | 100.00% |
Im Cannabis Corp Competitors by Market Cap
The table below lists competitors of Im Cannabis Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Proven Growth and Income Vct PLC
LSE:PGOO
|
$1.81 Million |
|
Canzon Israel Ltd
TA:CNZN
|
$1.81 Million |
|
Oldfields Holdings Ltd
AU:OLH
|
$1.81 Million |
|
INCUVO S.A. ZY -50
F:68X
|
$1.82 Million |
|
Medesis Pharma SA
PA:ALMDP
|
$1.80 Million |
|
Seoul Food Ind Co Ltd
KO:004415
|
$1.80 Million |
|
AGM Group Holdings Inc Class A
NASDAQ:AGMH
|
$1.80 Million |
|
CJ Seafood Corp. Pfd. Series 1
KO:011155
|
$1.80 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Im Cannabis Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,243,000 to -858,000, a change of -6,101,000 (-116.4%).
- Net loss of 11,319,000 reduced equity.
- New share issuances of 5,065,000 increased equity.
- Other comprehensive income decreased equity by 2,544,000.
- Other factors increased equity by 2,697,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.32 Million | -1319.23% |
| Share Issuances | $5.07 Million | +590.33% |
| Other Comprehensive Income | $-2.54 Million | -296.5% |
| Other Changes | $2.70 Million | +314.34% |
| Total Change | $- | -116.36% |
Book Value vs Market Value Analysis
This analysis compares Im Cannabis Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2003-12-31 | $88.54 | $0.29 | x |
| 2004-12-31 | $103.62 | $0.29 | x |
| 2005-12-31 | $71.10 | $0.29 | x |
| 2006-12-31 | $98.83 | $0.29 | x |
| 2007-12-31 | $121.40 | $0.29 | x |
| 2008-12-31 | $227.13 | $0.29 | x |
| 2009-12-31 | $264.89 | $0.29 | x |
| 2010-12-31 | $210.35 | $0.29 | x |
| 2011-12-31 | $204.40 | $0.29 | x |
| 2012-12-31 | $77.15 | $0.29 | x |
| 2013-12-31 | $65.94 | $0.29 | x |
| 2014-12-31 | $221.45 | $0.29 | x |
| 2015-12-31 | $220.56 | $0.29 | x |
| 2016-12-31 | $220.27 | $0.29 | x |
| 2017-12-31 | $210.30 | $0.29 | x |
| 2018-12-31 | $3.61 | $0.29 | x |
| 2019-12-31 | $6.63 | $0.29 | x |
| 2020-12-31 | $2.88 | $0.29 | x |
| 2021-12-31 | $33.99 | $0.29 | x |
| 2022-12-31 | $19.72 | $0.29 | x |
| 2023-12-31 | $6.77 | $0.29 | x |
| 2024-12-31 | $2.23 | $0.29 | x |
| 2025-12-31 | $-0.20 | $0.29 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Im Cannabis Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -20.68%
- • Asset Turnover: 1.72x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-81.12%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2003 | -86.16% | 0.00% | 0.00x | 1.14x | $-743.30K |
| 2004 | -0.51% | 0.00% | 0.00x | 1.13x | $-106.98K |
| 2005 | -102.16% | 0.00% | 0.00x | 1.35x | $-918.93K |
| 2006 | -42.24% | 0.00% | 0.00x | 1.16x | $-755.65K |
| 2007 | -31.89% | 0.00% | 0.00x | 1.19x | $-1.00 Million |
| 2008 | -22.24% | 0.00% | 0.00x | 1.01x | $-2.05 Million |
| 2009 | -14.68% | 0.00% | 0.00x | 1.03x | $-2.23 Million |
| 2010 | -7.78% | 0.00% | 0.00x | 1.10x | $-1.53 Million |
| 2011 | -6.00% | 0.00% | 0.00x | 1.12x | $-1.39 Million |
| 2012 | -161.05% | 0.00% | 0.00x | 0.03x | $-5.71 Million |
| 2013 | -7.10% | 0.00% | 0.00x | 0.01x | $-549.84K |
| 2014 | -0.33% | 0.00% | 0.00x | 0.00x | $-1.18 Million |
| 2015 | -0.40% | 0.00% | 0.00x | 0.00x | $-1.18 Million |
| 2016 | -0.14% | 0.00% | 0.00x | 0.00x | $-1.15 Million |
| 2017 | -1.10% | -2.84% | 480.48x | 0.00x | $-1.26 Million |
| 2018 | 16.53% | 32.38% | 140.45x | 0.00x | $664.80K |
| 2019 | -29.57% | -80.36% | 0.29x | 1.25x | $-9.76 Million |
| 2020 | -258.61% | -180.60% | 0.42x | 3.43x | $-29.81 Million |
| 2021 | -8.83% | -52.16% | 0.12x | 1.43x | $-37.89 Million |
| 2022 | -833.88% | -347.64% | 0.90x | 2.68x | $-191.16 Million |
| 2023 | -65.64% | -19.46% | 1.00x | 3.37x | $-10.94 Million |
| 2024 | -201.89% | -19.59% | 1.38x | 7.47x | $-11.11 Million |
| 2025 | 0.00% | -20.68% | 1.72x | 0.00x | $-11.23 Million |
Industry Comparison
This section compares Im Cannabis Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $236,113,024
- Average return on equity (ROE) among peers: -47.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Im Cannabis Corp (IMCC) | $-3.62 Million | -86.16% | N/A | $1.80 Million |
| Aurora Cannabis Inc (ACB) | $602.92 Million | -11.50% | 0.39x | $197.35 Million |
| Akanda Corp (AKAN) | $-3.83 Million | 0.00% | 0.00x | $1.51 Million |
| Akebia Ther (AKBA) | $74.01 Million | -330.87% | 6.15x | $340.21 Million |
| Alkermes Plc (ALKS) | $54.20 Million | -73.99% | 0.03x | $4.62 Billion |
| Amylyx Pharmaceuticals Inc (AMLX) | $-25.36 Million | 0.00% | 0.00x | $1.77 Billion |
| Amphastar P (AMPH) | $639.42 Million | 21.51% | 1.37x | $959.02 Million |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $346.79 Million | -104.36% | 9.57x | $3.81 Billion |
| Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) | $344.93 Million | 26.40% | 10.61x | $3.57 Billion |
| Anika Therapeutics Inc (ANIK) | $287.08 Million | 1.44% | 0.21x | $199.00 Million |
| ANI Pharmaceuticals Inc (ANIP) | $40.96 Million | 0.73% | 0.09x | $1.80 Billion |
About Im Cannabis Corp
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It provides medical cannabis dried flowers; and cannabis extracts under the IMC, BLKMT, WAGNERS, and LOT420 brands. The company serves medical patients. IM Cannabis Corp. was founded in 2008 and is headquartered in Tel Aviv-Yafo, Israel.